Digitalized solutions for future healthcare (DigiHealth)

Nowadays, vast amount of digital data is generated in all levels of health-related research. In DigiHealth profiling area, we will create a world-class multidisciplinary research-based hub for developing and validating digital technologies for data-driven health applications, valorizing University of Oulu’s strong expertise in medicine, wireless sensors and business combined with outstanding regional co-creation, thus responding to bottlenecks in health care and services through a wider uptake of eHealth solutions, interoperability and cost-effectiveness.

The research focus is highly multidisciplinary crossing the boundaries between university’s research focus areas and faculties. DigiHealth profiling area will be primarily coordinated and managed by strategic research focus institute Infotech Oulu.

Director: Prof. Simo Saarakkala, Scientific Director of Infotech Oulu
Vice director: Prof. Jarmo Reponen, Research Unit of Medical Imaging, Physics and Technology

Coordinator: Docent Tuire Salonurmi

Read more here

Fibrosis diseasome - Fibrosis as a shared risk factor in the etiology of complex chronic diseases and unhealthy aging

FIBROSIS DISEASOME is a profiling area in the Molecular and environmental basis for lifelong health strategic research focus area of the University of Oulu. It is funded by specific funding instrument of the Academy of Finland to strengthen the universities´ research profiles in Finland.

Fibrosis is a major contributing pathology in several chronic complex diseases. It is a scarring process where functional tissue is replaced by excess extracellular matrix leading eventually to organ failure and death. No effective therapy is available to cure or prevent fibrosis, which currently presents a major unmet need in medicine.

The goal is to generate fundamental new knowledge of the molecular and epidemiological basis of fibrosis in complex chronic diseases and unhealthy ageing. High discovery potential and rapid translation into novel therapeutics and diagnostics is facilitated by embedding in an innovative biomedical ecosystem to promote effective prevention and treatment of fibrosis.

The research is carried out in the university´s strategic research focus institutes Biocenter Oulu and Eudaimonia and the joint University of Oulu and Oulu University Hospital Medical Research Center, Faculty of Biochemistry and Molecular Medicine, Faculty of Medicine and Faculty of Humanities.

Director: Prof. Johanna Uusimaa, Scientific Director of Biocenter Oulu
Vice director: Prof. Anne Remes, Director of Medical Research Center, Dean of the Faculty of Medicine